Pricing Log in Create free account

Lipocine Inc. (LPCN) vs Tvardi Therapeutics, Inc. (TVRD)

Lipocine Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Lipocine Inc. and Tvardi Therapeutics, Inc. are of similar size ($14.3M and $13.9M). Tvardi Therapeutics, Inc. grew revenue faster over the last twelve months: −34.4% against −63.5%. Tvardi Therapeutics, Inc. has the higher net margin (0.00% vs −755.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Lipocine Inc. leads on 8 and Tvardi Therapeutics, Inc. on 7.

Valuation

Metric LPCN TVRD Biotechnology median
P/E n/m n/m 8.50
P/S 7.75 0.85 9.71
P/B 0.56 1.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.64 n/m 0.64
EV/Sales (5.21) 4.79 9.21
Earnings yield (126.35%) (276.24%) (33.15%)
Free cash flow yield (92.84%) (297.28%) (25.50%)

Profitability

Metric LPCN TVRD Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (800.80%) 0.00% 0.00%
Net margin (755.11%) 0.00% 0.00%
Free cash flow margin (713.02%) 0.00% 0.00%
Return on equity (60.94%) (126.19%) (56.36%)
Return on assets (55.89%) (85.08%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LPCN TVRD Biotechnology median
Revenue growth (TTM) (63.48%) (34.36%) 6.02%
EPS growth (last fiscal year) (93,988.89%) 79.51% 30.26%
Revenue growth, 5-year CAGR 64.32% (18.53%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LPCN TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.48 1.87 4.72
Net debt to EBITDA 1.42 1.15 0.96

Dividend

Metric LPCN TVRD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LPCN TVRD Biotechnology median
Market cap 13.85m 14.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack